Skip to content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Prognostic significance of RBP2-H1 variant of JARID1B in melanoma

  • Łukasz Kuźbicki1,
  • Dariusz Lange2,
  • Agata Stanek-Widera2 and
  • Barbara W. Chwirot1Email author
BMC Cancer201717:854

https://doi.org/10.1186/s12885-017-3836-x

Received: 17 December 2016

Accepted: 23 November 2017

Published: 15 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
17 Dec 2016 Submitted Original manuscript
20 Feb 2017 Reviewed Reviewer Report - George Blanck
24 Feb 2017 Reviewed Reviewer Report - Laura Gatti
23 May 2017 Author responded Author comments - Łukasz Kużbicki
Resubmission - Version 2
23 May 2017 Submitted Manuscript version 2
28 Sep 2017 Reviewed Reviewer Report - Laura Gatti
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
23 Nov 2017 Editorially accepted
15 Dec 2017 Article published 10.1186/s12885-017-3836-x

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Medical Biology, Faculty of Biology and Environment Protection, Nicolaus Copernicus University, Toruń, Poland
(2)
Department of Tumor Pathology, Oncology Center – Maria Skłodowska-Curie Institute, Gliwice, Poland

Advertisement